Insider trading activities (stock purchases, sales, and option exercises) reported by insiders of Vera Therapeutics, Inc. (VERA) since 2021 are shown in Table 1 and Table 2. Table 1 shows the monthly insider trading data of Vera Therapeutics, Inc.. Table 2 shows the detailed insider transactions. This company's CIK number is 1831828.
Total stock buying since 2021: $87,024,848.
Total stock sales since 2021: $71,483,617.
Total stock option exercises since 2021: $3,844,830.
| Insider Buying | Insider Sales | Option Exercises | ||||
|---|---|---|---|---|---|---|
| Year | Shares | Value | Shares | Value | Shares | Value |
| 2025 | 250,000 | $5,277,260 | 37,188 | $1,282,018 | 17,500 | $50,697 |
| 2024 | 161,290 | $4,999,990 | 2,236,684 | $67,830,441 | 337,611 | $2,284,565 |
| 2023 | 4,680,503 | $36,539,646 | 8,190 | $136,409 | 23,516 | $74,636 |
| 2022 | 958,331 | $14,207,978 | 121,471 | $2,234,749 | 438,833 | $1,434,932 |
| 2021 | 2,363,634 | $25,999,974 | 0 | $0 | 0 | $0 |
| Trading Period | Insider Buying | Insider Sales | Option Exercises | |||
|---|---|---|---|---|---|---|
| year-month | Shares | Value | Shares | Value | Shares | Value |
| 2025-06 | 250,000 | $5,277,260 | 0 | $0 | 0 | $0 |
| 2025-02 | 0 | $0 | 19,688 | $549,538 | 0 | $0 |
| 2025-01 | 0 | $0 | 17,500 | $732,480 | 17,500 | $50,697 |
| 2024-12 | 0 | $0 | 35,000 | $1,579,724 | 92,661 | $268,437 |
| 2024-11 | 0 | $0 | 50,000 | $2,463,274 | 50,000 | $144,849 |
| 2024-10 | 0 | $0 | 50,000 | $2,127,502 | 35,000 | $101,394 |
| 2024-09 | 0 | $0 | 32,101 | $1,282,845 | 15,625 | $45,265 |
| 2024-08 | 0 | $0 | 30,096 | $1,162,345 | 15,625 | $45,265 |
| 2024-05 | 0 | $0 | 30,837 | $1,312,369 | 28,872 | $194,913 |
| 2024-04 | 0 | $0 | 124,191 | $4,864,446 | 99,828 | $1,484,442 |
| 2024-03 | 0 | $0 | 834,459 | $34,137,936 | 0 | $0 |
| 2024-01 | 161,290 | $4,999,990 | 1,050,000 | $18,900,000 | 0 | $0 |
| 2023-12 | 0 | $0 | 0 | $0 | 13,516 | $35,236 |
| 2023-08 | 0 | $0 | 8,190 | $136,409 | 0 | $0 |
| 2023-07 | 0 | $0 | 0 | $0 | 10,000 | $39,400 |
| 2023-06 | 453,217 | $6,882,003 | 0 | $0 | 0 | $0 |
| 2023-03 | 191,452 | $1,372,680 | 0 | $0 | 0 | $0 |
| 2023-02 | 4,035,834 | $28,284,963 | 0 | $0 | 0 | $0 |
| 2022-12 | 0 | $0 | 21,923 | $402,961 | 21,923 | $193,584 |
| 2022-11 | 0 | $0 | 494 | $8,170 | 325,765 | $849,265 |
| 2022-10 | 0 | $0 | 8,590 | $168,647 | 8,590 | $67,148 |
| 2022-09 | 0 | $0 | 22,363 | $472,530 | 22,363 | $64,785 |
| 2022-08 | 0 | $0 | 30,055 | $594,850 | 29,067 | $124,083 |
| 2022-07 | 0 | $0 | 30,214 | $469,696 | 24,799 | $103,898 |
| Trade Date | Insider Name | Trade Type | Shares | Price ($) | Value ($) |
|---|---|---|---|---|---|
| 2025-06-24 | Enright Patrick G | Buy | 40,607 | 22.35 | 907,647 |
| 2025-06-23 | Enright Patrick G | Buy | 209,393 | 20.87 | 4,369,613 |
| 2025-02-26 | Fordyce Marshall (PRESIDENT AND CEO) | Sale | 9,075 | 27.93 | 253,510 |
| 2025-02-21 | Fordyce Marshall (PRESIDENT AND CEO) | Sale | 10,613 | 27.89 | 296,028 |
| 2025-01-08 | Fordyce Marshall (PRESIDENT AND CEO) | Sale | 17,500 | 41.86 | 732,480 |
| 2025-01-08 | Fordyce Marshall (PRESIDENT AND CEO) | Option Ex | 17,500 | 2.90 | 50,697 |
| 2024-12-19 | Fordyce Marshall (PRESIDENT AND CEO) | Option Ex | 57,661 | 2.90 | 167,043 |
| 2024-12-18 | Fordyce Marshall (PRESIDENT AND CEO) | Sale | 17,500 | 43.01 | 752,622 |
| 2024-12-18 | Fordyce Marshall (PRESIDENT AND CEO) | Option Ex | 17,500 | 2.90 | 50,697 |
| 2024-12-11 | Fordyce Marshall (PRESIDENT AND CEO) | Sale | 17,500 | 47.26 | 827,102 |
| 2024-12-11 | Fordyce Marshall (PRESIDENT AND CEO) | Option Ex | 17,500 | 2.90 | 50,697 |
| 2024-11-25 | Fordyce Marshall (PRESIDENT AND CEO) | Sale | 19,375 | 48.36 | 936,955 |
| 2024-11-25 | Fordyce Marshall (PRESIDENT AND CEO) | Option Ex | 19,375 | 2.90 | 56,129 |
| 2024-11-13 | Fordyce Marshall (PRESIDENT AND CEO) | Sale | 30,625 | 49.84 | 1,526,319 |
| 2024-11-13 | Fordyce Marshall (PRESIDENT AND CEO) | Option Ex | 30,625 | 2.90 | 88,720 |
| 2024-10-28 | Seidenberg Beth C | Sale | 15,000 | 48.78 | 731,640 |
| 2024-10-23 | Fordyce Marshall (PRESIDENT AND CEO) | Sale | 19,375 | 41.03 | 794,956 |
| 2024-10-23 | Fordyce Marshall (PRESIDENT AND CEO) | Option Ex | 19,375 | 2.90 | 56,129 |
| 2024-10-09 | Fordyce Marshall (PRESIDENT AND CEO) | Sale | 15,625 | 38.46 | 600,906 |
| 2024-10-09 | Fordyce Marshall (PRESIDENT AND CEO) | Option Ex | 15,625 | 2.90 | 45,265 |
| 2024-09-19 | Seidenberg Beth C | Sale | 13,823 | 42.31 | 584,795 |
| 2024-09-18 | Seidenberg Beth C | Sale | 2,653 | 42.01 | 111,441 |
| 2024-09-11 | Fordyce Marshall (PRESIDENT AND CEO) | Sale | 15,625 | 37.54 | 586,609 |
| 2024-09-11 | Fordyce Marshall (PRESIDENT AND CEO) | Option Ex | 15,625 | 2.90 | 45,265 |
| 2024-08-21 | Fordyce Marshall (PRESIDENT AND CEO) | Sale | 14,471 | 39.76 | 575,424 |
| 2024-08-14 | Fordyce Marshall (PRESIDENT AND CEO) | Sale | 15,625 | 37.56 | 586,921 |
| 2024-08-14 | Fordyce Marshall (PRESIDENT AND CEO) | Option Ex | 15,625 | 2.90 | 45,265 |
| 2024-05-16 | Young Joseph R (SVP, FINANCE, CHIEF ACCT OFFCR) | Sale | 20,651 | 42.62 | 880,228 |
| 2024-05-16 | Young Joseph R (SVP, FINANCE, CHIEF ACCT OFFCR) | Option Ex | 20,651 | 7.87 | 162,523 |
| 2024-05-15 | Young Joseph R (SVP, FINANCE, CHIEF ACCT OFFCR) | Sale | 10,186 | 42.42 | 432,141 |
| 2024-05-15 | Young Joseph R (SVP, FINANCE, CHIEF ACCT OFFCR) | Option Ex | 8,221 | 3.94 | 32,390 |
| 2024-04-10 | Young Joseph R (SVP, FINANCE, CHIEF ACCT OFFCR) | Sale | 5,714 | 40.00 | 228,560 |
| 2024-04-03 | Grant Sean (CHIEF FINANCIAL OFFICER) | Sale | 118,477 | 39.13 | 4,635,886 |
| 2024-04-03 | Grant Sean (CHIEF FINANCIAL OFFICER) | Option Ex | 99,828 | 14.87 | 1,484,442 |
| 2024-03-25 | Katabi Maha | Sale | 340,000 | 40.50 | 13,770,000 |
| 2024-03-22 | Katabi Maha | Sale | 413,450 | 40.51 | 16,748,859 |
| 2024-03-21 | Katabi Maha | Sale | 81,009 | 44.67 | 3,619,077 |
| 2024-01-30 | Katabi Maha | Buy | 161,290 | 31.00 | 4,999,990 |
| 2024-01-10 | Commodore Capital Lp | Sale | 1,050,000 | 18.00 | 18,900,000 |
| 2023-12-29 | Fordyce Marshall (President and CEO) | Option Ex | 13,516 | 2.61 | 35,236 |
| 2023-08-21 | Fordyce Marshall (President and CEO) | Sale | 5,210 | 16.66 | 86,777 |
| 2023-08-21 | Lin Celia (Chief Medical Officer) | Sale | 1,490 | 16.66 | 24,815 |
| 2023-08-21 | Curley Joanne (Chief Development Officer) | Sale | 1,490 | 16.66 | 24,817 |
| 2023-07-05 | Young Joseph R (SVP, Finance, Chief Acct Offcr) | Option Ex | 10,000 | 3.94 | 39,400 |
| 2023-06-23 | Grant Sean (Chief Financial Officer) | Buy | 5,000 | 16.60 | 83,000 |
| 2023-06-20 | Commodore Capital Lp | Buy | 448,217 | 15.17 | 6,799,003 |
| 2023-03-30 | Seidenberg Beth C (Director) | Buy | 2,300 | 7.24 | 16,652 |
| 2023-03-28 | Seidenberg Beth C (Director) | Buy | 23,908 | 7.24 | 173,189 |
| 2023-03-27 | Seidenberg Beth C (Director) | Buy | 1,633 | 7.25 | 11,831 |
| 2023-03-24 | Seidenberg Beth C (Director) | Buy | 1,833 | 7.24 | 13,272 |
| 2023-03-20 | Seidenberg Beth C (Director) | Buy | 15,252 | 7.21 | 110,027 |
| 2023-03-17 | Seidenberg Beth C (Director) | Buy | 74,045 | 7.12 | 526,904 |
| 2023-03-10 | Seidenberg Beth C (Director) | Buy | 48,003 | 7.16 | 343,509 |
| 2023-03-03 | Seidenberg Beth C (Director) | Buy | 1,000 | 7.25 | 7,245 |
| 2023-03-02 | Seidenberg Beth C (Director) | Buy | 23,378 | 7.24 | 169,326 |
| 2023-03-01 | Seidenberg Beth C (Director) | Buy | 100 | 7.25 | 725 |
| 2023-02-13 | Seidenberg Beth C (Director) | Buy | 10,072 | 7.20 | 72,488 |
| 2023-02-09 | Seidenberg Beth C (Director) | Buy | 400 | 7.25 | 2,900 |
| 2023-02-08 | Seidenberg Beth C (Director) | Buy | 45,357 | 7.22 | 327,477 |
| 2023-02-07 | Seidenberg Beth C (Director) | Buy | 87,956 | 7.08 | 622,728 |
| 2023-02-06 | Sofinnova Management X-a, L.l.c. | Buy | 285,714 | 7.00 | 1,999,998 |
| 2023-02-06 | Tammenoms Bakker Juliet (10% Owner) | Buy | 1,714,285 | 7.00 | 11,999,995 |
| 2023-02-06 | Enright Patrick G (Director) | Buy | 1,714,285 | 7.00 | 11,999,995 |
| 2023-02-06 | Seidenberg Beth C (Director) | Buy | 131,602 | 7.03 | 925,162 |
| 2023-02-03 | Seidenberg Beth C (Director) | Buy | 46,163 | 7.24 | 334,220 |
| 2022-12-16 | Curley Joanne (Chief Development Officer) | Sale | 2,212 | 19.64 | 43,454 |
| 2022-12-16 | Curley Joanne (Chief Development Officer) | Option Ex | 2,212 | 2.90 | 6,408 |
| 2022-12-13 | Curley Joanne (Chief Development Officer) | Sale | 12,811 | 18.23 | 233,582 |
| 2022-12-13 | Curley Joanne (Chief Development Officer) | Option Ex | 12,811 | 8.69 | 111,276 |
| 2022-12-12 | Curley Joanne (Chief Development Officer) | Sale | 6,900 | 18.25 | 125,925 |
| 2022-12-12 | Curley Joanne (Chief Development Officer) | Option Ex | 6,900 | 11.00 | 75,900 |
| 2022-11-16 | Fordyce Marshall (President and CEO) | Option Ex | 195,459 | 2.61 | 509,559 |
| 2022-11-09 | Curley Joanne (Chief Development Officer) | Sale | 494 | 16.54 | 8,170 |
| 2022-10-18 | Curley Joanne (Chief Development Officer) | Sale | 8,590 | 19.63 | 168,647 |
| 2022-10-18 | Curley Joanne (Chief Development Officer) | Option Ex | 8,590 | 7.82 | 67,148 |
| 2022-09-13 | Fordyce Marshall (President and CEO) | Sale | 22,363 | 21.13 | 472,530 |
| 2022-09-13 | Fordyce Marshall (President and CEO) | Option Ex | 22,363 | 2.90 | 64,785 |
| 2022-08-22 | Curley Joanne (Chief Development Officer) | Sale | 1,630 | 19.04 | 31,027 |
| 2022-08-22 | Curley Joanne (Chief Development Officer) | Option Ex | 1,630 | 11.00 | 17,930 |
| 2022-08-19 | Curley Joanne (Chief Development Officer) | Sale | 6,909 | 19.31 | 133,412 |
| 2022-08-19 | Curley Joanne (Chief Development Officer) | Option Ex | 6,909 | 6.76 | 46,684 |
| 2022-08-12 | Fordyce Marshall (President and CEO) | Sale | 20,528 | 20.16 | 413,803 |
| 2022-08-12 | Fordyce Marshall (President and CEO) | Option Ex | 20,528 | 2.90 | 59,469 |
| 2022-08-03 | Curley Joanne (Chief Development Officer) | Sale | 988 | 16.81 | 16,608 |
| 2022-07-19 | Curley Joanne (Chief Development Officer) | Sale | 11,444 | 16.28 | 186,319 |
| 2022-07-19 | Curley Joanne (Chief Development Officer) | Option Ex | 11,444 | 4.63 | 53,042 |
| 2022-07-14 | Curley Joanne (Chief Development Officer) | Sale | 9,104 | 15.15 | 137,943 |
| 2022-07-14 | Curley Joanne (Chief Development Officer) | Option Ex | 6,354 | 2.90 | 18,407 |
| 2022-07-07 | Curley Joanne (Chief Development Officer) | Sale | 9,666 | 15.05 | 145,434 |
| 2022-07-07 | Curley Joanne (Chief Development Officer) | Option Ex | 7,001 | 4.63 | 32,449 |
| 2022-06-22 | Curley Joanne (Chief Development Officer) | Sale | 1,545 | 15.02 | 23,198 |
| 2022-06-22 | Curley Joanne (Chief Development Officer) | Option Ex | 1,239 | 6.37 | 7,896 |
| 2022-06-17 | Curley Joanne (Chief Development Officer) | Sale | 5,887 | 15.05 | 88,611 |
| 2022-06-17 | Curley Joanne (Chief Development Officer) | Option Ex | 4,687 | 4.63 | 21,724 |
| 2022-06-15 | Grant Sean (Chief Financial Officer) | Buy | 5,000 | 13.60 | 68,005 |
| 2022-05-31 | Curley Joanne (Chief Development Officer) | Sale | 400 | 15.22 | 6,086 |
| 2022-05-31 | Curley Joanne (Chief Development Officer) | Option Ex | 400 | 6.37 | 2,549 |
| 2022-02-10 | Katabi Maha | Buy | 266,666 | 15.00 | 3,999,990 |
| 2022-02-10 | Tammenoms Bakker Juliet (10% Owner) | Buy | 333,333 | 15.00 | 4,999,995 |
| 2022-02-10 | Enright Patrick G (Director) | Buy | 333,333 | 15.00 | 4,999,995 |
| 2022-02-06 | Grant Sean (Chief Financial Officer) | Buy | 14,285 | 7.00 | 99,995 |
| 2022-02-06 | Young Joseph R (SVP, Finance, Chief Acct Offcr) | Buy | 5,714 | 7.00 | 39,998 |
| 2021-05-18 | Katabi Maha (Director) | Buy | 727,272 | 11.00 | 7,999,992 |
| 2021-05-18 | Enright Patrick G (Director) | Buy | 909,090 | 11.00 | 9,999,990 |
| 2021-05-18 | Powell Michael (10% Owner) | Buy | 727,272 | 11.00 | 7,999,992 |
Insider trading activities including stock purchases, stock sales, and option exercises of VERA listed in the above tables cannot be completely guaranteed as to their accuracy. For more insider trading information of Vera Therapeutics, Inc. (symbol VERA, CIK number 1831828) see the Securities and Exchange Commission (SEC) website.